News

BerriHealth Supports NET Cancer Research

BerriHealth, a leader in providing high-quality black raspberry powder for clinical trials and directly to consumers online, has donated a portion of their 2013 sales to New Orleans Louisiana Neuroendocrine Tumor Specialists (NOLANETS), led by Dr.…

NIH Clinical Trial: Unique Opportunity for Carcinoid & NET Cancer State-of-the-Art Scan

Imagine having a nuclear scan that can change the course of your health and future — at no charge! Carcinoid and NET (neuroendocrine tumor) cancer patients have this opportunity by participating in the National Institutes of Health (NIH) clinical…

First Global Carcinoid and Neuroendocrine Tumor Patient Survey

Participate in the first ever global survey specifically focused on NET (neuroendocrine tumor) cancer!

Please help the Carcinoid Cancer Foundation and the Caring for Carcinoid Foundation – both members of theInternational Neuroendocrine Cancer…

2014 National Carcinoid and NET Patient Conference — Registration Is Now Open

Carcinoid and NET (neuroendocrine tumor) cancer patients, caregivers and family members, as well as physicians and other health professionals, have a unique opportunity to learn more about NET cancer, including the latest information about diagnosis…

New Jersey Carcinoid Cancer NETwork Conference Videos Now Online

Carcinoid and neuroendocrine tumor (NET) patients, physicians, caregivers, support group leaders and patient advocates gathered to learn more from nationally and internationally recognized carcinoid/NET specialists and local physician specialists…

Annual Appeal 2013

Please read our Annual Appeal letter from Jeffrey M. Gregory as he talks about how the Carcinoid Cancer Foundation made a significant difference for him and his wife, Jackie.  Read more about Jackie’s Journey with carcinoid.  Donations to the Annual …

Endurance Competitive Rider and Goblet Cell Carcinoid Cancer Survivor Takes on New International Challenge

Battling goblet cell carcinoid cancer has not deterred Monica Grundmann from pursuing her dream as an endurance rider with her Morab stallion, Excalibur Legend.  Next month Monica will represent Eastern Canada in the North American Team Challenge …

Dr. M. Sue O’Dorisio Receives $100,000 Grant for Neuroendocrine Tumor Research

Congratulations to carcinoid/neuroendocrine tumor specialist Dr. M. Sue O’Dorisio of the University of Iowa who is one of five researchers across the country selected to receive a $100,000 “springboard grant to jumpstart a promising investigation.”…

FDA Grants Orphan Drug Designation to Gallium-68 DOTATOC for Neuroendocrine Tumor Management

BREAKING NEWS – The radiopharmaceutical Gallium-68 (DOTA0-hel-Tyr3) octreotide (Ga-68 DOTATOC) has been designated as an orphan drug by the US Food and Drug Administration (FDA) for the management of neuroendocrine tumors. This designation is significant…

NET Cancer Day 2013 Webinar Features Three Leading Carcinoid/NET Specialists

In recognition of Worldwide NET Cancer Awareness Day on November 10, NorCal CarciNet is hosting a one-hour, free webinar. Here’s a great opportunity to hear from 3 of the leading specialists in carcinoid/NET cancer treatment on NET CANCER DAY: Professor…